JXR repurchases 1.29 million shares on 21 May; buy-back shares awaiting cancellation reach 33.18 million, representing 1.23% of share capital

Bulletin Express
05/21

Jinxin Fertility Group Limited (JXR) filed a Next Day Disclosure Return outlining the latest progress of its on-market share repurchase programme.

Key takeaways

1. Latest transaction • Date: 21 May 2026 • Shares repurchased: 1.29 million ordinary shares • Price range: HKD 2.28–2.29 per share • Aggregate consideration: HKD 2.96 million

2. Cumulative repurchases pending cancellation • Between 27 March and 21 May 2026, JXR bought back 33.18 million shares for cancellation that have not yet been cancelled. • These shares equal 1.23 % of the company’s 2.71 billion issued shares outstanding as of 21 May 2026.

3. Share capital position • Opening and closing issued share count (excluding shares pending cancellation): 2.71 billion. • No new shares were issued during the period covered by the return.

4. Repurchase mandate utilisation • Shares authorised for repurchase: 274.47 million (shareholder mandate dated 26 June 2025). • Shares repurchased under the mandate to date: 72.84 million, representing 2.65 % of the share count at the time the mandate was granted.

5. Moratorium on new share issues Under Hong Kong Listing Rule 10.06(3)(a), JXR may not issue new shares until 20 June 2026 following the latest buy-back.

The filing confirms that all repurchases were executed in accordance with the Hong Kong Listing Rules and the company’s shareholder mandate.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10